Asthika Goonewardene
Stock Analyst at Truist Securities
(2.09)
# 1,511
Out of 4,412 analysts
61
Total ratings
38.98%
Success rate
-5.87%
Average return
Main Sectors:
Top Industries:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Maintains: Buy | $25 → $18 | $3.42 | +426.32% | 5 | Apr 3, 2024 | |
| MRUS Merus | Initiates: Buy | $69 | $45.04 | +53.20% | 1 | Mar 28, 2024 | |
| GMAB Genmab | Maintains: Buy | $50 | $28.15 | +77.62% | 9 | Mar 26, 2024 | |
| CGEN Compugen | Maintains: Buy | $4 → $5 | $1.92 | +160.42% | 4 | Mar 8, 2024 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $17 → $26 | $11.64 | +123.37% | 5 | Mar 7, 2024 | |
| ACLX Arcellx | Maintains: Buy | $57 → $87 | $51.92 | +67.57% | 3 | Mar 5, 2024 | |
| MRSN Mersana Therapeutics | Upgrades: Buy | $9 | $2.94 | +206.12% | 3 | Feb 29, 2024 | |
| CRGX CARGO Therapeutics | Initiates: Buy | $34 | $18.68 | +82.01% | 1 | Dec 5, 2023 | |
| EXEL Exelixis | Reiterates: Buy | $32 | $23.70 | +35.02% | 3 | Sep 13, 2023 | |
| IGMS IGM Biosciences | Reiterates: Buy | $25 | $9.40 | +165.96% | 5 | Sep 6, 2023 | |
| HOOK HOOKIPA Pharma | Reiterates: Buy | $4 | $0.89 | +347.78% | 4 | Sep 6, 2023 | |
| ACET Adicet Bio | Reiterates: Buy | $27 | $1.68 | +1,507.14% | 2 | Sep 6, 2023 | |
| AUTL Autolus Therapeutics | Maintains: Buy | $6 → $9 | $4.00 | +125.00% | 3 | Aug 17, 2023 | |
| CRBU Caribou Biosciences | Reiterates: Buy | $23 | $3.71 | +519.95% | 2 | Jul 14, 2023 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $20 → $18 | $2.89 | +522.84% | 3 | Jul 12, 2023 | |
| TIL Instil Bio | Reinstates: Hold | $120 | $10.60 | +1,032.08% | 1 | Apr 5, 2023 | |
| CELU Celularity | Maintains: Hold | $100 → $60 | $3.02 | +1,886.75% | 3 | Aug 23, 2022 | |
| NXTC NextCure | Maintains: Buy | $19 → $15 | $1.35 | +1,011.11% | 4 | Aug 23, 2022 |
Sutro Biopharma
Apr 3, 2024
Maintains: Buy
Price Target: $25 → $18
Current: $3.42
Upside: +426.32%
Merus
Mar 28, 2024
Initiates: Buy
Price Target: $69
Current: $45.04
Upside: +53.20%
Genmab
Mar 26, 2024
Maintains: Buy
Price Target: $50
Current: $28.15
Upside: +77.62%
Compugen
Mar 8, 2024
Maintains: Buy
Price Target: $4 → $5
Current: $1.92
Upside: +160.42%
Iovance Biotherapeutics
Mar 7, 2024
Maintains: Buy
Price Target: $17 → $26
Current: $11.64
Upside: +123.37%
Arcellx
Mar 5, 2024
Maintains: Buy
Price Target: $57 → $87
Current: $51.92
Upside: +67.57%
Mersana Therapeutics
Feb 29, 2024
Upgrades: Buy
Price Target: $9
Current: $2.94
Upside: +206.12%
CARGO Therapeutics
Dec 5, 2023
Initiates: Buy
Price Target: $34
Current: $18.68
Upside: +82.01%
Exelixis
Sep 13, 2023
Reiterates: Buy
Price Target: $32
Current: $23.70
Upside: +35.02%
IGM Biosciences
Sep 6, 2023
Reiterates: Buy
Price Target: $25
Current: $9.40
Upside: +165.96%
HOOKIPA Pharma
Sep 6, 2023
Reiterates: Buy
Price Target: $4
Current: $0.89
Upside: +347.78%
Adicet Bio
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $1.68
Upside: +1,507.14%
Autolus Therapeutics
Aug 17, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $4.00
Upside: +125.00%
Caribou Biosciences
Jul 14, 2023
Reiterates: Buy
Price Target: $23
Current: $3.71
Upside: +519.95%
Allogene Therapeutics
Jul 12, 2023
Maintains: Buy
Price Target: $20 → $18
Current: $2.89
Upside: +522.84%
Instil Bio
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $10.60
Upside: +1,032.08%
Celularity
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $3.02
Upside: +1,886.75%
NextCure
Aug 23, 2022
Maintains: Buy
Price Target: $19 → $15
Current: $1.35
Upside: +1,011.11%